Is non-ablative 1550-nm fractional photothermolysis an effective modality to treat melasma? Results from a prospective controlled single-blinded trial in 51 patients

Journal of the European Academy of Dermatology and Venereology

Volumn 26, Issue 4, 2012, Pages 470-476

  Karsai, S ^a,b   Fischer, T ^c   Pohl, L ^a   Schmitt, L ^d   Buhck, H ^e   Junger M ^b   Raulin, C ^a,f  

^a LASERKLINIK KARLSRUHE   (Germany)

^b UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^c Skin and Laser Centre Potsdam   (Germany)

^d KLINIKUM LUDWIGSHAFEN   (Germany)

^e Office of Biomedical Statistics   (Germany)

^f UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CHLOASMA; CLINICAL ASSESSMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENSITY; ENERGY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELASMA AREA AND SEVERITY INDEX; NON ABLATIVE FRACTIONAL PHOTOTHERMOLYSIS; PATIENT SATISFACTION; PHOTOTHERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; SAFETY; SCORING SYSTEM; SINGLE BLIND PROCEDURE; TREATMENT DURATION;

ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MELANOSIS; MIDDLE AGED; PHOTOTHERAPY; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD;

EID: 84858866751     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2011.04100.x     Document Type: Review

References (23)

1. Pandya AG, Guevara IL,. Disorders of hyperpigmentation. Dermatol Clin 2000; 18: 91-98.
2. Grimes PE,. Melasma. Etiologic and therapeutic considerations. Arch Dermatol 1995; 131: 1453-1457.
3. Mosher DB, Fitzpatrick TB, Ortonne J-P, Hori Y,. Hypomelanoses and hypermelanoses. In:, Freedberg IM, Eisen AZ, Wolff K, et al. eds. Fitzpatrick's Dermatology in General Medicine, Vol 1. McGraw-Hill, New York, 1999: 945-1017.
4. Lee HI, Lim YY, Kim BJ, et al. Clinicopathologic efficacy of copper bromide plus/yellow laser (578 nm with 511 nm) for treatment of melasma in Asian patients. Dermatol Surg 2010; 36: 885-893.
5. Balkrishnan R, McMichael AJ, Camacho FT, et al. Development and validation of a health-related quality of life instrument for women with melasma. Br J Dermatol 2003; 149: 572-577. (Pubitemid 37281590)
6. Lynde CB, Kraft JN, Lynde CW,. Topical treatments for melasma and postinflammatory hyperpigmentation. Skin Therapy Lett 2006; 11: 1-6.
7. Rendon M, Berneburg M, Arellano I, Picardo M,. Treatment of melasma. J Am Acad Dermatol 2006; 54: 272-281.
8. Manaloto RM, Alster T,. Erbium:YAG laser resurfacing for refractory melasma. Dermatol Surg 1999; 25: 121-123. (Pubitemid 30195951)
9. 2 laser and Q-switched alexandrite laser compared with Q-switched alexandrite laser alone for refractory melasma: split-face design. Dermatol Surg 2003; 29: 59-64. (Pubitemid 36114731)
10. Tannous ZS, Astner S,. Utilizing fractional resurfacing in the treatment of therapy-resistant melasma. J Cosmet Laser Ther 2005; 7: 39-43. (Pubitemid 40896751)
11. Rokhsar CK, Fitzpatrick RE,. The treatment of melasma with fractional photothermolysis: a pilot study. Dermatol Surg 2005; 31: 1645-1650. (Pubitemid 43031166)
12. Naito SK,. Fractional photothermolysis treatment for resistant melasma in Chinese females. J Cosmet Laser Ther 2007; 9: 161-163. (Pubitemid 47347220)
13. Goldberg DJ, Berlin AL, Phelps R,. Histologic and ultrastructural analysis of melasma after fractional resurfacing. Lasers Surg Med 2008; 40: 134-138. (Pubitemid 351354769)
14. Laubach HJ, Tannous Z, Anderson RR, Manstein D,. Skin responses to fractional photothermolysis. Lasers Surg Med 2006; 38: 142-149.
15. Katz TM, Glaich AS, Goldberg LH, et al. Treatment of melasma using fractional photothermolysis: a report of eight cases with long-term follow-up. Dermatol Surg 2010; 36: 1273-1280.
16. Manstein D, Herron GS, Sink RK, et al. Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg Med 2004; 34: 426-438. (Pubitemid 38890753)
17. Hantash BM, Bedi VP, Sudireddy V, et al. Laser-induced transepidermal elimination of dermal content by fractional photothermolysis. J Biomed Opt 2006; 11: 041115.
18. Sherling M, Friedman PM, Adrian R, et al. Consensus recommendations on the use of an erbium-doped 1,550-nm fractionated laser and its applications in dermatologic laser surgery. Dermatol Surg 2010; 36: 461-469.
19. Taylor S, Westerhof W, Im S, Lim J,. Noninvasive techniques for the evaluation of skin color. J Am Acad Dermatol 2006; 54: S282-S290.
20. Kimbrough-Green CK, Griffiths CE, Finkel LJ, et al. Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial. Arch Dermatol 1994; 130: 727-733. (Pubitemid 24182681)
21. Wind BS, Kroon MW, Meesters AA, et al. Non-ablative 1,550 nm fractional laser therapy versus triple topical therapy for the treatment of melasma: a randomized controlled split-face study. Lasers Surg Med 2010; 42: 607-612.
22. Lee HS, Won CH, Lee DH, et al. Treatment of melasma in Asian skin using a fractional 1,550-nm laser: an open clinical study. Dermatol Surg 2009; 35: 1499-1504.
23. Kang WH, Yoon KH, Lee ES, et al. Melasma: histopathological characteristics in 56 Korean patients. Br J Dermatol 2002; 146: 228-237. (Pubitemid 34264392)